Abstract
Plantar fasciitis (PF) usually responds to conservative treatment, but some cases are challenging to manage. New biological therapies have been suggested for multiple soft tissue problems and are gradually gaining the interest of the scientific world. Platelet-rich plasma (PRP), autologous whole blood (AWB), bone marrow aspirate concentrate (BMAC), and placental tissue extracts are new available strategies to manage PF. They fall under the umbrella name of orthobiologics: naturally derived substances from the human body having the ability to promote bones, joints, muscles, and tendons healing. Prolotherapy, instead, consists of a natural irritant, hyperosmolar glucose, injected into the soft tissues to cause osmotic desiccation and potential death of local cells, triggering a healing response. All these strategies can be used in PF treatment, replacing the current widespread use of corticosteroids and avoiding surgical release.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lapidus PW, Guidotti FP. Painful heel: report of 323 patients with 364 painful heels. Clin Orthop. 1965;39:178–86.
Riddle DL, Pulisic M, Pidcoe P, Johnson RE. Risk factors for plantar fasciitis: a matched case-control study. J Bone Joint Surg Am. 2003;85(5):872–7.
Riddle DL, Schappert SM. Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis: a national study of medical doctors. Foot Ankle Int. 2004;25(5):303–10.
Levy JC, Mizel MS, Clifford PD, Temple HT. Value of radiographs in the initial evaluation of nontraumatic adult heel pain. Foot Ankle Int. 2006;27(6):427–30.
American Orthopaedic Foot and Ankle Society. Position statement: endoscopic and open heel surgery; 2010.
Porter MD, Shadbolt B. Intralesional corticosteroid injection versus extracorporeal shock wave therapy for plantar fasciopathy. Clin J Sport Med Off J Can Acad Sport Med. 2005;15(3):119–24.
Sammarco GJ, Helfrey RB. Surgical treatment of recalcitrant plantar fasciitis. Foot Ankle Int. 1996;17(9):520–6.
Davies MS, Weiss GA, Saxby TS. Plantar fasciitis: how successful is surgical intervention? Foot Ankle Int. 1999;20(12):803–7.
Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008;1(3–4):165–74.
Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2012;28(3):429–39.
Lee KS, Wilson JJ, Rabago DP, Baer GS, Jacobson JA, Borrero CG. Musculoskeletal applications of platelet-rich plasma: fad or future? AJR Am J Roentgenol. 2011;196(3):628–36.
Neufeld SK, Cerrato R. Plantar fasciitis: evaluation and treatment. J Am Acad Orthop Surg. 2008;16(6):338–46.
Mahindra P, Yamin M, Selhi HS, Singla S, Soni A. Chronic plantar fasciitis: effect of platelet-rich plasma, corticosteroid, and placebo. Orthopedics. 2016;39(2):e285–9.
Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int. 2014;35(4):313–8.
Say F, Gürler D, İnkaya E, Bülbül M. Comparison of platelet-rich plasma and steroid injection in the treatment of plantar fasciitis. Acta Orthop Traumatol. 2014;48(6):667–72.
Ragab EMS, Othman AMA. Platelets rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg. 2012;132(8):1065–70.
Martinelli N, Marinozzi A, Carnì S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop. 2013;37(5):839–42.
Kumar V, Millar T, Murphy PN, Clough T. The treatment of intractable plantar fasciitis with platelet-rich plasma injection. Foot (Edinb). 2013;23(2–3):74–7.
Akşahin E, Doğruyol D, Yüksel HY, Hapa O, Doğan Ö, Çelebi L, et al. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg. 2012;132(6):781–5.
Sami M, Nassr MH, Hamdy M, Khalil A. Preliminary study reveals the efficiency of platelet rich plasma injection over physiotherapy for chronic plantar fasciitis treatment. Int J Clin Rheumatol. 2019;14(3):120.
Franceschi F, Papalia R, Franceschetti E, Paciotti M, Maffulli N, Denaro V. Platelet-rich plasma injections for chronic plantar fasciopathy: a systematic review. Br Med Bull. 2014;112(1):83–95.
Kirmani T, Gul I, Waris Q, Kangoo K. Autologous whole blood injection in chronic plantar fasciitis: a prospective clinical study. Int J Res Orthop. 2018;4:634.
Tabrizi A, Dindarian S, Mohammadi S. The effect of corticosteroid local injection versus platelet-rich plasma for the treatment of plantar fasciitis in obese patients: a single-blind, randomized clinical trial. J Foot Ankle Surg Off Publ Am Coll Foot Ankle Surg. 2020;59(1):64–8.
Acosta-Olivo C, Elizondo-Rodriguez J, Lopez-Cavazos R, Vilchez-Cavazos F, Simental-Mendia M, Mendoza-Lemus O. Plantar fasciitis-a comparison of treatment with intralesional steroids versus platelet-rich plasma a randomized, blinded study. J Am Podiatr Med Assoc. 2017;107(6):490–6.
Ryan MB, Wong AD, Gillies JH, Wong J, Taunton JE. Sonographically guided intratendinous injections of hyperosmolar dextrose/lidocaine: a pilot study for the treatment of chronic plantar fasciitis. Br J Sports Med. 2009;43(4):303–6.
Chen C-M, Chen J-S, Tsai W-C, Hsu H-C, Chen K-H, Lin C-H. Effectiveness of device-assisted ultrasound-guided steroid injection for treating plantar fasciitis. Am J Phys Med Rehabil. 2013;92(7):597–605.
Ersen Ö, Koca K, Akpancar S, Seven MM, Akyıldız F, Yıldız Y, et al. A randomized-controlled trial of prolotherapy injections in the treatment of plantar fasciitis. Turk J Phys Med Rehabil. 2018;64(1):59–65.
Seven M, Koca K, Akpancar S, Turkkan S, Uysal B, Yildiz Y, et al. Prolotherapy injections in the treatment of overuse injuries. Balk Mil Med Rev. 2016;19:1.
Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Prim Care. 2010;37(1):65–80.
Dorman TA. Prolotherapy: a survey. J Orthop Med. 1993;15(2):49–50.
Uğurlar M, Sönmez MM, Uğurlar ÖY, Adıyeke L, Yıldırım H, Eren OT. Effectiveness of four different treatment modalities in the treatment of chronic plantar fasciitis during a 36-month follow-up period: a randomized controlled trial. J Foot Ankle Surg Off Publ Am Coll Foot Ankle Surg. 2018;57(5):913–8.
Harford JS, Dekker TJ, Adams SB. Bone marrow aspirate concentrate for bone healing in foot and ankle surgery. Foot Ankle Clin. 2016;21(4):839–45.
Cavinatto L, Hinckel BB, Tomlinson RE, Gupta S, Farr J, Bartolozzi AR. The role of bone marrow aspirate concentrate for the treatment of focal chondral lesions of the knee: a systematic review and critical analysis of animal and clinical studies. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2019;35(6):1860–77.
Chahla J, Dean CS, Moatshe G, Pascual-Garrido C, Serra Cruz R, LaPrade RF. Concentrated bone marrow aspirate for the treatment of chondral injuries and osteoarthritis of the knee: a systematic review of outcomes. Orthop J Sports Med. 2016;4(1):2325967115625481.
Courneya J-P, Luzina IG, Zeller CB, Rasmussen JF, Bocharov A, Schon LC, et al. Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes. Fibrogenesis Tissue Repair. 2010;3:9.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.
Cottom JM, Plemmons BS. Bone marrow aspirate concentrate and its uses in the foot and ankle. Clin Podiatr Med Surg. 2018;35(1):19–26.
Werber B. Amniotic tissues for the treatment of chronic plantar fasciosis and achilles tendinosis. J Sports Med. 2015;2015:e219896.
Fetterolf D, Snyder R. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds Compend Clin Res Pract. 2012;24:299–307.
Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88–99.
Cazzell S, Stewart J, Agnew PS, Senatore J, Walters J, Murdoch D, et al. Randomized controlled trial of micronized dehydrated human amnion/chorion membrane (dHACM) injection compared to placebo for the treatment of plantar fasciitis. Foot Ankle Int. 2018;39(10):1151–61.
Zelen CM, Poka A, Andrews J. Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis—a feasibility study. Foot Ankle Int. 2013;34(10):1332–9.
Hanselman AE, Tidwell JE, Santrock RD. Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study. Foot Ankle Int. 2015;36(2):151–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 ISAKOS
About this chapter
Cite this chapter
Tarulli, F.R., Aletto, C., Maffulli, N. (2022). Orthobiologics for the Treatment of Plantar Fasciitis. In: Filardo, G., Mandelbaum, B.R., Muschler, G.F., Rodeo, S.A., Nakamura, N. (eds) Orthobiologics. Springer, Cham. https://doi.org/10.1007/978-3-030-84744-9_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-84744-9_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84743-2
Online ISBN: 978-3-030-84744-9
eBook Packages: MedicineMedicine (R0)